Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy

Published:2020-01 Issue:1 Volume:15 Page:26-41
ISSN:1818-0876
Container-title:Asian Journal of Pharmaceutical Sciences
language:en
Short-container-title:Asian Journal of Pharmaceutical Sciences

Author:

Zhou Xiaohan,Shi Kun,Hao Ying,Yang Chengli,Zha Ruoyu,Yi Cheng,Qian Zhiyong

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference125 articles.

1. The ErbB/HER family of protein-tyrosine kinases and cancer;Roskoski;Pharmacol Res,2014

2. The potential of panHER inhibition in cancer;Wang;Front Oncol,2015

3. Epidermal growth factor receptor targeting in cancer: a review of trends and strategies;Yewale;Biomaterials,2013

4. Dacomitinib, an emerging HER-targeted therapy for non-small cell lung cancer;Carpenter;J Thorac Dis,2012

5. Intracellular fate of a targeted delivery system;Patra;J Biomed Nanotechnol,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-based targeted therapy through EGFR tyrosine kinase inhibitors and their recent advances in lung cancer therapy;Exploration of Medicine;2024-07-14

2. Application of nanoscale metal–organic frameworks in tumor immunotherapy;Rare Metals;2024-06-18

3. Moving beyond traditional therapies: the role of nanomedicines in lung cancer;Frontiers in Pharmacology;2024-02-08

4. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment;International Journal of Molecular Sciences;2024-01-23

5. Prodigiosin/celecoxib-loaded into zein/sodium caseinate nanoparticles as a potential therapy for triple negative breast cancer;Scientific Reports;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3